Tag Archives: Digital Therapeutics Market

As a result of the escalating prevalence of chronic diseases, the need to contain escalating healthcare expenditures and continuous technological progress, the digital therapeutics market is anticipated to expand at a CAGR of 32.1% between 2024 and 2032. Nonetheless, the implementation of streamlined validation processes is significantly impeded by regulatory obstacles, which require collaborative endeavors. Unique patterns in application emphasis, ...